Aspirin use for the primary prevention of myocardial infarction among men in north Carolina, 2013

Preventing Chronic Disease

Volumn 12, Issue 11, 2015, Pages

  Tchwenko, Samuel ^a,b   Fleming, Eleanor ^c   Perry, Geraldine S ^c  

^a North Carolina Division of Public Health   (United States)

^b IL   (United States)

^c NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

AGED; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; DIABETES MELLITUS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NORTH CAROLINA; PRIMARY PREVENTION; RISK ASSESSMENT; SMOKING;

AGED; ASPIRIN; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; DIABETES MELLITUS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NORTH CAROLINA; PLATELET AGGREGATION INHIBITORS; PRIMARY PREVENTION; RISK ASSESSMENT; SMOKING;

EID: 84958974042     PISSN: 15451151     EISSN: 21665435     Source Type: Journal    
DOI: 10.5888/pcd12.150342     Document Type: Article

References (27)

1. About underlying cause of death, 1999-2013. Atlanta (GA):US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2015. http://wonder.cdc.gov/ucd-icd10.html. Accessed July 2, 2015.
2. 2013 BRFSS survey results: North Carolina. Chronic health conditions. Raleigh (NC): North Carolina Department of Health and Human Services, Division of Public Health, State Center for Health Statistics; 2014. http://www.schs.state.nc.us/data/brfss/2013/nc/all/CVDINFR4.html. Accessed August 20, 2015.
3. About compressed mortality, 1999-2013. Atlanta (GA): US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2014. http://wonder.cdc.gov/cmf-icd10.html. Accessed August 20, 2015.
4. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005;352(13):1293-304.
5. Centers for Disease Control and Prevention (CDC). Million Hearts: strategies to reduce the prevalence of leading cardiovascular disease risk factors - United States, 2011. MMWR Morb Mortal Wkly Rep 2011;60(36):1248-51.
6. US Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009; 150(6):396-404.
7. Shahar E, Folsom AR, Romm FJ, Bisgard KM, Metcalf PA, Crum L, et al. Patterns of aspirin use in middle-aged adults: the Artherosclerosis Risk in Communities (ARIC) Study. Am Heart J 1996;131(5)915-22.
8. Stafford RS, Radley DC. The underutilization of cardiac medications of proven benefit, 1990 to 2002. J Am Coll Cardiol 2003;41(1):56-61.
9. Kim C, Beckles GL. Cardiovascular disease risk reduction in the Behavioral Risk Factor Surveillance System. Am J Prev Med 2004;27(1):1-7.
10. Pignone M, Anderson GK, Binns K, Tilson HH, Weisman SM. Aspirin use among adults aged 40 and older in the United States: results of a national survey. Am J Prev Med 2007; 32(5):403-7.
11. Rivera CM, Song J, Copeland L, Buirge C, Ory M, McNeal CJ. Underuse of aspirin for primary and secondary prevention of cardiovascular disease events in women. J Womens Health (Larchmt) 2012;21(4):379-87.
12. VanWormer JJ, Greenlee RT, McBride PE, Peppard PE, Malecki KC, Che J, et al. Aspirin for primary prevention of CVD: are the right people using it? J Fam Pract 2012; 61(9):525-32.
13. The BRFSS data user guide, August 15, 2013. Atlanta (GA):Centers for Disease Control and Prevention; 2013. http://www.cdc.gov/brfss/data_documentation/PDF/UserguideJune2013.pdf. Accessed July 24, 2014.
14. Little RJA, Rubin DB. Wiley series in probability and statistics: statistical analysis with missing data. 2nd edition. Somerset (NJ): Wiley; 2014.
15. Coronary heart disease risk calculator. Milwaukee (WI):Medical College of Wisconsin. http://www.mcw.edu/calculators/Coronary-Heart-Disease-Risk.htm#.UGnbyE1TzTp. Accessed July 20, 2014.
16. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97(18):1837-47.
17. Mallonee S, Daniels CG, Mold JW, Cline TL. Increasing aspirin use among persons at risk for cardiovascular events in Oklahoma. J Okla State Med Assoc 2010;103(7):254-60.
18. Ajani UA, Ford ES, Greenland KJ, Giles WH, Mokdad AH. Aspirin use among U.S. adults: Behavioral Risk Factor Surveillance System. Am J Prev Med 2006;30(1):74-7.
19. Mainous AG, Tanner RJ, Shorr RI, Limacher MC. Use of aspirin for primary and secondary cardiovascular disease prevention in the United States, 2011-2012. J Am Heart Assoc 2014; 3(4): e000989.
20. George MG, Tong X, Sonnenfeld N, Hong Y, Centers for Disease Control and Prevention. Recommended use of aspirin and other antiplatelet medications among adults - National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey, United States, 2005-2008. MMWR Morb Mortal Wkly Rep 2012;61(Suppl):11-8.
21. Preventive Services Covered Under the Affordable Care Act. Washington (DC): U.S. Department of Health and Human Services. http://www.hhs.gov/healthcare/facts/factsheets/2010/07/preventive-services-list.html. Accessed October 1, 2015.
22. Ebrahim S, Taylor F, Ward K, Beswick A, Burke M, Davey Smith G. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev 2011;(1):CD001561.
23. Institute of Medicine. Primary care and public health:exploring integration to improve population health. Washington (DC): The National Academies Press; 2012.
24. Oldenburg NC, Duval S, Luepker RV, Finnegan JR, LaMarre H, Peterson KA, et al. A 16-month community-based intervention to increase aspirin use for primary prevention of cardiovascular disease. Prev Chronic Dis 2014; 11(5): E83.
25. Centers for Disease Control and Prevention (CDC). Methodologic changes in the Behavioral Risk Factor Surveillance System in 2011 and potential effects on prevalence estimates. MMWR Morb Mortal Wkly Rep 2012; 61(22):410-3.
26. Simpson C, Massing M, Simpson RJ. The Million Hearts initiative: applying the ABCS of healthy hearts in North Carolina. N C Med J 2012;73(6):476-80.
27. Bertoni AG, Ensley D, Goff DC. 30,000 fewer heart attacks and strokes in North Carolina: a challenge to prioritize prevention. N C Med J 2012;73(6):449-56.